Pediatric Hematology and Oncology

We work with children and their families to treat cancers and blood disorders.

Learn more or make an appointment

717-531-6807

Experienced blood and cancer care

The Division of Pediatric Hematology and Oncology at Penn State Children's Hospital cares for infants, children, adolescents and young adults with cancer and blood disorders. We use a team approach, working with other children’s health experts as needed. The patient and family is always at the center of care. Our hematology and oncology programs are recognized by U.S. News and World Report as a Best Children’s Hospital.

Hematology (blood) services

Hematology is the study of blood disorders. Hematologists are doctors who test for and treat blood disorders. Our Pediatric Hematology team cares for children with all types of blood disorders, including:

Our Pediatric Hematology experts help children and their families through testing, treatment and recovery, as well as provide counseling for families as needed.

Learn more about our hematology services.

Oncology (cancer) services

Oncology is the study of cancer and tumors. Oncologists are doctors who treat cancer and tumors. Our Pediatric Oncology team provides advanced care for children with every type of cancer, including:

  • Hematologic malignancies (leukemias, lymphoma)
  • Brain tumors
  • All solid tumors

Patients who have completed treatment with us participate in our Childhood Cancer Survivorship Program in order to address the unique needs of childhood cancer survivors. 

Learn more about our oncology services.

Research and clinical trials

Penn State Children’s Hospital is dedicated to advancing care and treatment for cancer and blood disorders. We take part in a variety of clinical trials available to our patients. Clinical trials evaluate new drugs or treatments, and answer questions about treating, diagnosing, preventing or managing cancer symptoms or treatment effects. 

Contact us

Scheduling: 717-531-6807
Fax: 717-531-4789

Academic Office: 717-531-6012

U.S. News & World Report